HealthQuill chronic pain
Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor that may cure chronic pain without using opioids.
Drugs Health Pharma

Eli Lilly to buy SiteOne to grab test inhibitor to treat chronic pain

HQ Team May 28, 2025: Eli Lilly and Company will acquire SiteOne Therapeutics, Inc. for $1 billion to get access to an inhibitor.

Read More
Health

Researchers develop innovative non-addictive painkiller for chronic pain

HQ Team November 13, 2024: A team of international researchers has developed a non-addictive painkiller that remains inactive until it reaches sites of.

Read More